Stock Scorer

Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings, Inc. reported revenue of 88K USD for the quarter ending 30 June 2026, down 89.5% from 836K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 88K -89.5%
Gross Profit Q2 '26 · ending 30 June 2026 63K -92.0%
Operating Income Q2 '26 · ending 30 June 2026 -22.4M —
Net Income Q2 '26 · ending 30 June 2026 -23.8M —
Cost of Revenue Q2 '26 · ending 30 June 2026 25K -45.7%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -19.3M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -19.6M —
Shares Outstanding Q2 '26 · ending 30 June 2026 63.8M +66.9%
EPS Q2 '26 · ending 30 June 2026 -0.83 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 33.5M-51.8M-52.7M-49.5M
20242024-12-31 2.6M-64.3M-61M-50.8M
20232023-12-31 2.8M-51.5M-49.1M-46.2M
20222022-12-31 3.5M-32.7M-33.6M-29.9M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3088K
Q1 '262026-03-31110K
Q4 '252025-12-3130.9M
Q3 '252025-09-30861K
Q2 '252025-06-30836K
Q1 '252025-03-31868K
Q4 '242024-12-31253K
Q3 '242024-09-30987K
Q2 '242024-06-30778K
Q1 '242024-03-31620K
Q4 '232023-12-31262K
Q3 '232023-09-30419K
Q2 '232023-06-30915K
Q1 '232023-03-311.2M
Q4 '222022-12-311.1M
Q3 '222022-09-301.2M
Q2 '222022-06-30401K
Q1 '222022-03-31866K

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-3063K
Q1 '262026-03-3178K
Q4 '252025-12-3130.9M
Q3 '252025-09-30812K
Q2 '252025-06-30790K
Q1 '252025-03-31824K
Q4 '242024-12-31195K
Q3 '242024-09-30919K
Q2 '242024-06-30734K
Q1 '242024-03-31586K
Q4 '232023-12-31215K
Q3 '232023-09-30378K
Q2 '232023-06-30861K
Q1 '232023-03-311.1M
Q4 '222022-12-311.1M
Q3 '222022-09-301.1M
Q2 '222022-06-30341K
Q1 '222022-03-31824K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-22.4M
Q1 '262026-03-31-22.1M
Q4 '252025-12-316.8M
Q3 '252025-09-30-20.3M
Q2 '252025-06-30-19.3M
Q1 '252025-03-31-18.9M
Q4 '242024-12-31-16.7M
Q3 '242024-09-30-16.3M
Q2 '242024-06-30-16.9M
Q1 '242024-03-31-14.4M
Q4 '232023-12-31-12.5M
Q3 '232023-09-30-14.5M
Q2 '232023-06-30-13M
Q1 '232023-03-31-11.5M
Q4 '222022-12-31-9.8M
Q3 '222022-09-30-10.1M
Q2 '222022-06-30-7.6M
Q1 '222022-03-31-5.1M
Q4 '212021-12-31-92K
Q3 '212021-09-30-94.4K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-23.8M
Q1 '262026-03-31-20.7M
Q4 '252025-12-316.2M
Q3 '252025-09-30-20.8M
Q2 '252025-06-30-19.4M
Q1 '252025-03-31-18.8M
Q4 '242024-12-31-16.2M
Q3 '242024-09-30-15.4M
Q2 '242024-06-30-16M
Q1 '242024-03-31-13.5M
Q4 '232023-12-31-12.8M
Q3 '232023-09-30-13.3M
Q2 '232023-06-30-12M
Q1 '232023-03-31-10.9M
Q4 '222022-12-31-9.8M
Q3 '222022-09-30-10.3M
Q2 '222022-06-30-7.8M
Q1 '222022-03-31-5.7M
Q4 '212021-12-31-88K
Q3 '212021-09-30-90.4K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3025K
Q1 '262026-03-3132K
Q4 '252025-12-3151K
Q3 '252025-09-3049K
Q2 '252025-06-3046K
Q1 '252025-03-3144K
Q4 '242024-12-3158K
Q3 '242024-09-3068K
Q2 '242024-06-3044K
Q1 '242024-03-3134K
Q4 '232023-12-3147K
Q3 '232023-09-3041K
Q2 '232023-06-3054K
Q1 '232023-03-3144K
Q4 '222022-12-3153K
Q3 '222022-09-3056K
Q2 '222022-06-3060K
Q1 '222022-03-3142K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-19.3M
Q1 '262026-03-31-22.2M
Q4 '252025-12-31-2.3M
Q3 '252025-09-30-14.6M
Q2 '252025-06-30-15.5M
Q1 '252025-03-31-16.6M
Q4 '242024-12-31-13.5M
Q3 '242024-09-30-13.7M
Q2 '242024-06-30-10.2M
Q1 '242024-03-31-13.1M
Q4 '232023-12-31-11M
Q3 '232023-09-30-10.3M
Q2 '232023-06-30-10.5M
Q1 '232023-03-31-14.4M
Q4 '222022-12-31-8.7M
Q3 '222022-09-30-7.3M
Q2 '222022-06-30-8M
Q1 '222022-03-31-5.3M
Q4 '212021-12-31-28.8K
Q3 '212021-09-30-128K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-19.6M
Q1 '262026-03-31-22.4M
Q4 '252025-12-31-2.3M
Q3 '252025-09-30-14.9M
Q2 '252025-06-30-15.6M
Q1 '252025-03-31-16.7M
Q4 '242024-12-31-13.6M
Q3 '242024-09-30-13.8M
Q2 '242024-06-30-10.3M
Q1 '242024-03-31-13.1M
Q4 '232023-12-31-11M
Q3 '232023-09-30-10.3M
Q2 '232023-06-30-10.5M
Q1 '232023-03-31-14.4M
Q4 '222022-12-31-8.8M
Q3 '222022-09-30-7.5M
Q2 '222022-06-30-8.2M
Q1 '222022-03-31-5.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3063.8M
Q1 '262026-03-3162.7M
Q3 '252025-09-3052.2M
Q2 '252025-06-3038.4M
Q1 '252025-03-3138.2M
Q3 '242024-09-3037.6M
Q2 '242024-06-3035.8M
Q1 '242024-03-3135.8M
Q3 '232023-09-3035.2M
Q2 '232023-06-3034.6M
Q1 '232023-03-3127.6M
Q3 '222022-09-3020.2M
Q2 '222022-06-3010.1M
Q1 '222022-03-319.2M
Q3 '212021-09-3020.4M
Q2 '212021-06-3020.4M
Q1 '212021-03-3120.4M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.83
Q1 '262026-03-31-0.95
Q4 '252025-12-31-1.11
Q3 '252025-09-30-1.82
Q2 '252025-06-30-1.83
Q1 '252025-03-31-1.78
Q4 '242024-12-31-1.67
Q3 '242024-09-30-1.61
Q2 '242024-06-30-1.58
Q1 '242024-03-31-1.48
Q4 '232023-12-31-1.50
Q3 '232023-09-30-1.57
Q2 '232023-06-30-1.70
Q1 '232023-03-31-2.12
Q4 '222022-12-31-2.34
Q3 '222022-09-30-1.91
Q2 '222022-06-30-1.40
Q1 '222022-03-31-0.63
Q4 '212021-12-31-0.01
Q3 '212021-09-300.00